LABORATORIO FARMAC.ERFO (F:RK7) — Market Cap & Net Worth
Market Cap & Net Worth: LABORATORIO FARMAC.ERFO (RK7)
LABORATORIO FARMAC.ERFO (F:RK7) has a market capitalization of $9.59 Million (€8.20 Million) as of June 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #27142 globally and #2352 in its home market, demonstrating a 4.99% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LABORATORIO FARMAC.ERFO's stock price €0.97 by its total outstanding shares 8520000 (8.52 Million). Review RK7 total liabilities to assess the company's total debt and financial obligations.
LABORATORIO FARMAC.ERFO Market Cap History: 2022 to 2026
LABORATORIO FARMAC.ERFO's market capitalization history from 2022 to 2026. Data shows change from $14.73 Million to $9.64 Million (-11.68% CAGR).
LABORATORIO FARMAC.ERFO Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LABORATORIO FARMAC.ERFO's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.87x
LABORATORIO FARMAC.ERFO's market cap is 1.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
19.99x
LABORATORIO FARMAC.ERFO's market cap is 19.99 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $14.73 Million | $4.72 Million | $716.07K | 3.12x | 20.57x |
| 2023 | $11.07 Million | $5.93 Million | $553.82K | 1.87x | 19.99x |
Competitor Companies of RK7 by Market Capitalization
Companies near LABORATORIO FARMAC.ERFO in the global market cap rankings as of June 19, 2026.
Key companies related to LABORATORIO FARMAC.ERFO by market ranking:
- Nestlé S.A (F:NESM): Ranked #87 globally with a market cap of $224.33 Billion USD ( €191.89 Billion EUR).
- Nestle S.A. (SW:NESN): Ranked #97 globally with a market cap of $204.31 Billion USD ( CHF161.60 Billion CHF).
- Danone SA (PA:BN): Ranked #550 globally with a market cap of $49.46 Billion USD ( €42.31 Billion EUR).
- Danone SA (F:BSND): Ranked #705 globally with a market cap of $39.05 Billion USD ( €33.40 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Nestlé S.A | F:NESM | $224.33 Billion | €85.40 |
| #97 | Nestle S.A. | SW:NESN | $204.31 Billion | CHF78.96 |
| #550 | Danone SA | PA:BN | $49.46 Billion | €65.70 |
| #705 | Danone SA | F:BSND | $39.05 Billion | €12.80 |
LABORATORIO FARMAC.ERFO Historical Marketcap From 2022 to 2026
Between 2022 and today, LABORATORIO FARMAC.ERFO's market cap moved from $14.73 Million to $ 9.64 Million, with a yearly change of -11.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €9.64 Million | -18.66% |
| 2025 | €11.85 Million | +25.00% |
| 2024 | €9.48 Million | -14.37% |
| 2023 | €11.07 Million | -24.84% |
| 2022 | €14.73 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of LABORATORIO FARMAC.ERFO was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.59 Million USD |
| MoneyControl | $9.59 Million USD |
| MarketWatch | $9.59 Million USD |
| marketcap.company | $9.59 Million USD |
| Reuters | $9.59 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LABORATORIO FARMAC.ERFO
Laboratorio Farmaceutico Erfo S.p.A. engages in the formulation and production of food supplements in Italy. It produces various types of pharmaceutical forms, such as bottles, single-dose vials and bottles, capsules, tablets, and sachets under the Diètnatural and Gianopharma brands, as well as private label brands. The company offers custom formula creation, regulatory advice, graphics, and pack… Read more